Wasdell makes multimillion-pound investment in new packaging equipment
The contract packaging company has plans to install new equipment for the company’s blister and bottle lines, vial labelling, stability chambers and cold storage capacity.
Wasdell Group, a pharmaceutical outsourcing partner, has confirmed it is making a multimillion-pound investment in new packaging equipment across its UK and Ireland sites.
The specialist in end-to-end supply chain service provider made the decision to invest in line with increasing demand for its manufacturing and packaging capabilities from its growing pharma and biotech client portfolio.
The investment, which is part of a long-term investment plan to expand the company's capacity and capabilities, includes equipment for the company’s blister and bottle lines, vial labelling, stability chambers and cold storage capacity.
The equipment will be installed across all Wasdell’s sites in the UK and Ireland, including the recently opened Dundalk facility.
In addition to meeting increased demand, Vincent Dunne, CEO at Wasdell, explained the company's new packaging equipment will "allow us to maintain the swift turnaround times and flexible service we are well known for in the industry".
According to Martin Tedham, Wasdell Group Chairman, the investment will also support the company's expanding customer base, particularly US life sciences companies that want to "source a provider that can readily navigate the European market and specialises in small-mid batch sizes.”
Related News
-
News US BIOSECURE Act passed by US House of Representatives
The controversial act, which has already impacted several foreign companies operating in the US, was passed by the House of Representatives on September 9, 2024. It is now headed for the US Senate before it can be signed into law by President Joe Biden... -
News Pharma Supply Chain People Moves
The latest appointments, promotions, and structural changes across the pharmaceutical supply chain. -
News Drug prices agreed upon as part of the US Inflation Reduction Act
The Inflation Reduction Act brought into constitution by the Biden administation in 2022, which proposed a drug price negotiation between the government and pharmaceutical companies, has reached it's first agreement. -
News BIOSECURE Act continues to loom over Chinese pharma manufacturers
With the US BIOSECURE Act on its way to passing into legislation, Chinese companies are facing declining revenues within the first half of 2024 as US pharmaceutical and healthcare companies pull their businesses from the country. -
News Ophthalmologic drug product Eylea faces biosimilar threats after FDA approvals
Regeneron Pharmaceutical’s blockbuster ophthalmology drug Eylea is facing biosimilar competition as the US FDA approves Biocon’s Yesafili and Samsung Bioepis/Biogen’s Opuviz. -
News ONO Pharmaceutical expands oncology portfolio with acquisition of Deciphera
ONO Pharmaceutical, out of Japan, is in the process of acquiring cancer-therapy maker Deciphera Pharmaceuticals for US$2.4 billion. -
News First offers for pharma from Medicare drug price negotiations
Ten high-cost drugs from various pharma manufacturers are in pricing negotiations in a first-ever for the US Medicare program. President Biden’s administration stated they have responded to the first round of offers. -
News Eli Lilly’s Zepbound makes leaps and bounds in weight-loss drug market
In the last week, Eli Lilly has announced their partnership with Amazon.com’s pharmacy unit to deliver prescriptions of Zepbound. Zepbound has also surpassed Novo Nordisk’s Wegovy for the number of prescriptions for the week of March 8.&nbs...
Position your company at the heart of the global Pharma industry with a CPHI Online membership
-
Your products and solutions visible to thousands of visitors within the largest Pharma marketplace
-
Generate high-quality, engaged leads for your business, all year round
-
Promote your business as the industry’s thought-leader by hosting your reports, brochures and videos within your profile
-
Your company’s profile boosted at all participating CPHI events
-
An easy-to-use platform with a detailed dashboard showing your leads and performance